Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000387844 | SCV001365917 | likely pathogenic | Deficiency of alpha-mannosidase | 2019-08-19 | criteria provided, single submitter | clinical testing | The p.Cys501X variant in MAN2B1 has not been previously reported in individuals with alpha-mannosidosis and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 501, which is predicted to lead to a truncated or absent protein. Loss of function of the MAN2B1 gene is an established disease mechanism in autosomal recessive alpha-mannosidosis. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive alpha-mannosidosis. ACMG/AMP Criteria applied: PVS1, PM2. |